![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=825640837178066&get_thumbnail=1)
jp morgan glp-1
Shipping Estimate
jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://cdn.koreabiomed.com/news/photo/202601/30323_32586_90.jpeg)
![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=900550791375608&get_thumbnail=1)
![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://www.foodbusinessnews.net/ext/resources/2026/04/08/Screenshot-2026-04-08-072616.webp?t=1775651417&width=696)
![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3865707033601323595)
![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://athletechnews.com/wp-content/uploads/2024/06/shutterstock_editorial_1465185422-2.webp)
![jp morgan glp-1 After a big year for GLP-1s, the biopharma market is shifting. Chris Schott offers his 2026 outlook ahead of the 44th annual J.P. Healthcare Conference. JPM 2026] D&D Pharmatech chose](https://i.ytimg.com/vi/LgOYS-YeBvc/oar2.jpg?sqp=-oaymwEYCJUDENAFSFqQAgHyq4qpAwcIARUAAIhC&rs=AOn4CLDfPmCeJ9SdXwQKeJxHBF3gE95hwQ&usqp=CCk)
